RxDoctor Payments DataLook up a doctor →

Bincy Abraham, MD

Gastroenterology · Houston, TXNPI 1578767166

Payments from drug & device makers

$2,542,238in general payments, 2019–2025

Across 2,346 payments — averaging $1083.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$527K
  • E.r. Squibb & Sons, L.L.C.$302K
  • Pfizer$281K
  • Takeda Pharmaceuticals U.S.A., Inc.$278K
  • Johnson & Johnson$141K
  • Eli Lilly$127K
  • plus $887K from 53 others
$2,106in research payments, 2019–2025

Across 2 payments — averaging $1053.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie622$526,538
E.r. Squibb & Sons, L.L.C.90$301,788
Pfizer292$281,365
Takeda Pharmaceuticals U.S.A., Inc.199$278,300
Johnson & Johnson(2 entities)325$140,663
Eli Lilly34$126,669
Lilly USA, LLC132$119,783
Janssen Scientific Affairs, LLC131$117,817
Janssen Research & Development, LLC35$103,296
Roche Products Limited46$93,309
Bristol Myers Squibb120$89,178
Boehringer Ingelheim International GmbH7$65,315
Celltrion USA Inc.56$55,045
Takeda2$45,513
Sanofi25$38,420
UCB, Inc.68$36,138
Gilead9$32,534
UCB SA1$13,500
F. Hoffmann-la Roche AG4$13,169
Celltrion Healthcare Canada Ltd.5$12,271
Boehringer Ingelheim Pharma GmbH & Co.kg9$10,450
Ferring Pharmaceuticals Inc.9$10,109
UCB Biosciences Inc.4$9,860
Fresenius Kabi USA, LLC5$4,914
Janssen Global Services, LLC2$4,445
Canon Medical Systems USA, Inc.2$2,859
Quidel Corporation1$1,500
Ironwood Pharmaceuticals, Inc3$1,335
Abbott5$1,071
Pharmacosmos Therapeutics Inc.6$819
Celltrion Healthcare Co., Ltd1$700
Samsung Bioepis Co., Ltd.1$500
Regeneron Healthcare Solutions, Inc.9$490
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$386
Covidien LP7$344
Biogen2$300
Amgen8$172
Phathom Pharmaceuticals, Inc.2$151
Pentax Of America, Inc.1$151
Ferring International Pharmascience Center US1$125
Aimmune Therapeutics, Inc.5$120
Ardelyx, Inc.3$101
Merck4$95
Braintree Laboratories, Inc.5$92
Shire North American Group Inc5$76
Medtronic1$71
Olympus America Inc.2$66
Intercept Pharmaceuticals, Inc.1$57
QOL Medical, LLC3$50
Daiichi Sankyo Inc.2$33
Madrigal Pharmaceuticals1$27
Ipsen Biopharmaceuticals, Inc1$26
Siemens Medical Solutions USA, Inc.1$25
Alcresta Therapeutics, Inc.1$24
Boehringer Ingelheim1$18
Shield Therapeutics Inc1$18
Blueprint Medicines Corporation1$18
Cook Medical LLC1$17
Shionogi Inc1$12

How this compares

$2,542,238 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024
$1,486,313
Medicare patients
199
Services billed
79,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →